TIDMVLG

RNS Number : 2871F

Venture Life Group PLC

11 July 2019

11 July 2019

Venture Life Group plc

("Venture Life" or the "Group")

Director dealings

Venture Life Group plc (AIM: VLG), a leader in developing, manufacturing and commercialising products for the international self-care market, announces that Carl Dempsey, Non-Executive Director, today purchased 20,000 ordinary shares of 0.3 pence each in the capital of the Company ("Ordinary Shares") at a price of 51.4999 pence per share.

Following this purchase, Mr Dempsey is interested in 20,000 Ordinary Shares, representing approximately 0.02% of the issued share capital of the Company.

For further information, please contact:

 
 Venture Life Group PLC                               +44(0) 1344 578004 
 Jerry Randall, Chief Executive Officer 
 
 Cenkos Securities Ltd (Nomad and Broker)             +44(0)20 7397 8900 
 Mark Connelly / Stephen Keys / Cameron 
  MacRitchie (Corporate Finance) 
 Russell Kerr / Michael Johnson (Sales) 
 
                                                      +44(0)20 3405 
 Alma PR                                               0208 
 Rebecca Sanders-Hewett / Hilary Buchanan / Helena 
  Bogle / Jessica Joynson

About Venture Life (www.venture-life.com)

Venture Life is an international consumer self-care company focused on developing, manufacturing and commercialising products for the global self-care market. With operations in both the UK and Italy, the Group's product portfolio includes some key products such as the UltraDEX and Dentyl oral care product ranges, food supplements for maintaining brain function, medical devices for women's intimate healthcare and proctology and dermo-cosmetics for addressing the signs of ageing.

The products, which are typically recommended by pharmacists or healthcare practitioners, are available primarily through pharmacies and grocery multiples. In the UK these are supplied direct by the company, outside of the UK they are supplied by the Group's international distribution partners.

Through its Development & Manufacturing business in Italy, Biokosmes, the Group also provides development and manufacturing services to companies in the medical devices and cosmetic sectors.

The Company makes the following disclosures in accordance with article 19(3) of the Market Abuse Regulation:

 
  1   Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                         Carl Dempsey 
     ---------------------------  ----------------------------------- 
 2    Reason for the notification 
     ---------------------------------------------------------------- 
 a)   Position/status              Non-Executive Director 
     ---------------------------  ----------------------------------- 
 b)   Initial notification         Initial Notification 
       /Amendment 
     ---------------------------  ----------------------------------- 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
     ---------------------------------------------------------------- 
 a)   Name                         Venture Life Group plc 
     ---------------------------  ----------------------------------- 
 b)   LEI                          213800S8CZUPLAB2KC70 
     ---------------------------  ----------------------------------- 
 4    Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of 
       transaction; (iii) each date; and (iv) each place where 
       transactions have been conducted 
     ---------------------------------------------------------------- 
 a)   Description of               Ordinary Shares of 0.3p each in 
       the financial                Venture Life Group plc 
       instrument, type 
       of instrument 
     ---------------------------  ----------------------------------- 
 b)   Identification               GB00BFPM8908 
       code 
     ---------------------------  ----------------------------------- 
 c)   Nature of the                Purchase of Ordinary Shares 
       transaction 
     ---------------------------  ----------------------------------- 
 d)   Price and volumes             Share Purchase 
                                     20,000 shares 
                                     51.4999 pence 
                                     GBP10,299.98 
     ---------------------------  ----------------------------------- 
 d)   Aggregated information 
       - Aggregated                  N/A - single trade 
       volume 
       - Price 
     ---------------------------  ----------------------------------- 
 e)   Date of the transaction      11 July 2019 
     ---------------------------  ----------------------------------- 
 f)   Place of the                 London Stock Exchange 
       transaction 
     ---------------------------  -----------------------------------

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHLLFFSDAILLIA

(END) Dow Jones Newswires

July 11, 2019 10:33 ET (14:33 GMT)

Grafico Azioni Venture Life (LSE:VLG)
Storico
Da Mar 2024 a Apr 2024 Clicca qui per i Grafici di Venture Life
Grafico Azioni Venture Life (LSE:VLG)
Storico
Da Apr 2023 a Apr 2024 Clicca qui per i Grafici di Venture Life